The North America Blepharoplasty Market would witness market growth of 6.8% CAGR during the forecast period (2022-2028).
Doctors are increasingly using non-surgical techniques to do eyelid surgery owing to their many advantages over traditional surgical approaches. Different from conventional surgical practices, modern technology techniques do not have these issues, which often include many operations, anesthesia, and a lengthy recovery period.
Examples of contemporary technologies that are inexpensive, non-invasive, and have an immediate impact include those that use plasma exeresis. These sorts of technological advancements are predicted to drive the blepharoplasty market expansion throughout the course of the projection.
According to the surgical strategy, the patient's preferences, the requirement for concurrent procedures, and the surgeon's desire, blepharoplasty may be done under local or general anesthesia. With local anesthesia, a straightforward upper or lower eyelid blepharoplasty is possible when just skin or fat is removed. Some more invasive treatments, such as endoscopic browlifts, mid-face lifts, and lower blepharoplasty coupled with fat redistribution, could need intravenous sedation or general anesthesia.
The increasing demand for skin tightening in the United States can largely be attributed to the increase in the proportion of the population aged 65 and older, as well as the aspiration to maintain economic and social participation. As a result of this, people between the ages of 35 and 50 go in for preventative medical operations such as skin rejuvenation and skin tightening. Even among guys, there has been a notable uptick in interest in undergoing cosmetic surgical procedures. In addition, players in the market are focusing their efforts on the introduction of brand-new items to increase their revenue share within the North American region.
The US market dominated the North America Blepharoplasty Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,626.8 Million by 2028. The Canada market is poised to grow at a CAGR of 8.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8.6% during (2022 - 2028).
Based on Type, the market is segmented into Upper Eyelid, Lower Eyelid and Combination Eyelid Surgery. Based on Gender, the market is segmented into Female and Male. Based on End User, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centre. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Blepharoplasty Market is Estimated to reach $5.7 Billion by 2028, at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Sisram Medical Ltd (Fosun Pharma), AbbVie, Inc., LightScalpel, Inc, Surgical Holdings, GRAND AESPIO, INC., London Bridge Plastic Surgery, Medline Industries, Inc., and Lumenis Be Ltd.
By Type
By Gender
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
